Amylyx price target lowered to $3 from $4 at Baird
PremiumThe FlyAmylyx price target lowered to $3 from $4 at Baird
4M ago
Amylyx to hold a conference call
PremiumThe Fly
Amylyx to hold a conference call
4M ago
Amylyx shares interim data from  AMX0035 trial for adults with Wolfram syndrome
PremiumThe Fly
Amylyx shares interim data from AMX0035 trial for adults with Wolfram syndrome
4M ago
Amylyx announces formal intention to remove RELYVRIO/ALBRIOZA from market
PremiumThe FlyAmylyx announces formal intention to remove RELYVRIO/ALBRIOZA from market
4M ago
Class Action against Amylyx Pharmaceuticals Inc. (AMLX)
PremiumMarket News
Class Action against Amylyx Pharmaceuticals Inc. (AMLX)
4M ago
Unusually active option classes on open March 19th
PremiumThe Fly
Unusually active option classes on open March 19th
4M ago
Baird downgrades Amylyx, sees Relyvrio being withdrawn soon
PremiumThe FlyBaird downgrades Amylyx, sees Relyvrio being withdrawn soon
5M ago
Amylyx downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Amylyx downgraded to Market Perform from Outperform at Leerink
5M ago
Amylyx downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Amylyx downgraded to Neutral from Outperform at Baird
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100